Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02185404 · ClinicalTrials.gov registry record · NA

iStride(TM) Device Used for Stroke Rehabilitation

A NA study of Stroke, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02185404: Completed NA study of Stroke, sponsored by University of South Florida.

NCT02185404 is a NA study of Stroke that has completed, run by University of South Florida. The registered enrollment target is 6 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02185404, a NA study of Stroke, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The objective of this research is to test a passive shoe to correct gait in individuals with asymmetric walking patterns. This will be done in a clinic. Individuals with central nervous system damage, such as stroke, often have irregular walking patterns and have difficulty walking correctly. Recent research has shown that using a split-belt treadmill can create after-effects that temporarily correct the inefficient walking patterns. However, the corrected walking pattern does not efficiently transfer from the treadmill to walking over ground. The iStride, formerly known as the Gait Enhancing Mobile Shoe (GEMS), may allow a patient to practice walking in many different locations, such as their own home, which we hypothesize will result in a more permanent transfer of learned gait patterns. To enable long-term use, our proposed shoe design is passive and uses the wearer's natural forces exerted while walking to generate the necessary motions.

Primary Outcome

During a symmetric gait, step lengths on each side are the same; during an asymmetric gait, step lengths are different. We will quantify the amount of adaptation and the change in gait asymmetry by comparing the magnitude of step length difference between baseline and after four weeks of training (three training sessions per week). Step length asymmetry is a standard accepted measure for measuring gait asymmetry. To measure the gait, a Gait Up Physilog sensor, a ProtoKinetics Zeno Walkway, or a

Conditions Studied

Interventions

  • DEVICE wearing the iStride device

Study Locations (1)

Florida

  • University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2016-01-28
Est. Completion 2017-12-15
Phase NA
University of South Florida

252 total trials

What the finished NCT02185404 record still lists

NCT02185404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which wearing the iStride device is the first listed.

NCT02185404 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT02185404 about?

NCT02185404 is a clinical study titled "iStride(TM) Device Used for Stroke Rehabilitation". The objective of this research is to test a passive shoe to correct gait in individuals with asymmetric walking patterns. This will be done in a clinic. Individuals with central nervous system damage, such as stroke, often have irregular walking patterns and have difficulty walking correctly. Recent...

What is the current status of trial NCT02185404?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2016-01-28. Estimated completion is 2017-12-15.

What conditions does trial NCT02185404 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT02185404?

The interventions under investigation include: wearing the iStride device (DEVICE).

Who is sponsoring clinical trial NCT02185404?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02185404 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02185404's enrollment target sits among peer trials

6 433rd of 454 higher than 17 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02185404, the US trial registry maintained by the National Library of Medicine. NCT02185404 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.